|
Wednesday 6th April 2022 |
Text too small? |
Green Cross Health announces the appointment of Craig Brockliss to the Board, effective 6 April 2022. Mr Brockliss will stand for election at the Annual Shareholders’ Meeting currently scheduled to be held on 25 July 2022.
In accordance with Rule 2.6.1 of the NZX Listing Rules, the Board has determined that Mr Brockliss is a non-independent director due to a disqualifying relationship with substantial product holder Wilton Asset Management Limited, currently the third largest Green Cross Health shareholder.
Craig Brockliss is CEO of the Wilton Capital Group of companies and has more than 20 years’ experience in business, property and private equity investing. Wilton Capital has significant investment interests in both New Zealand, the United States and in the UK.
Wilton Capital has its origins in the pharmaceutical logistics markets in New Zealand and Australia before diversifying into other investments in 2001.
Craig holds a Bachelor of Commerce and a Bachelor of Laws from the University of Auckland and worked for Ernst and Young prior to joining the Wilton Group in 2001.
Kim Ellis
Chair
ENDS
No comments yet
August 25th Morning Report
CNU - Board change, closing date for director nominations, & ASM
PFI - PFI Announces FY26 Annual Results
August 24th Morning Report
SKL - Shareholder Register Release
SPN - South Port Delivers Record FY26 Result
GEN - Amended Annual Shareholders Meeting 2026 Results
TWL - TradeWindow to seek primary ASX listing; appoints Australia
AIA - Annual Meeting and Nomination of Directors
FPH provides first half FY27 guidance, updates FY27 outlook